SEER logo

SEER Seer, Inc.

NASDAQ Global Select · Biotechnology · Healthcare

$2.25
+0.05 (+2.27%)

Seer, Inc. is a life sciences firm specializing in developing and commercializing advanced technologies designed to unravel the complexities of the proteome. At the core of its offerings is the Proteograph Product Suite, an integrated platform comprising specialized consumables, automated instrumentation, and sophisticated software. This comprehensive solution empowers researchers to conduct advan…

Market Cap: $123.71Mseer.bio

Price

No data yet.

Social Signal Score

42
5d
—
30d
30
2 mentions
—
60d
48
5 mentions
—
90d
48
5 mentions
—
news: 5

Analyst Ratings

4 analysts
Holdconsensus
Strong Buy 0Buy 1Hold 2Sell 1Strong Sell 0
Avg price target$4+77.8%
Low $4Median $4High $4
Current Consensus

Revenue

$3.10M+5248.28%
$0.00$1.39M$2.79M$4.18M
Dec 2019Jun 2026

Analyst Estimates

FY2025
$-1.31
$-1.40–$-1.22
1 analysts
FY2026
$-1.10
$-1.18–$-1.02
1 analysts
FY2027
$-1.05
$-1.13–$-0.98
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Omid C. Farokhzad
Sector
Healthcare
Industry
Biotechnology
Employees
124
Beta
1.51
Country
US
Piotroski score
3 / 9 (Weak)
Altman Z-score
-0.43
seer.bio